Haine Yael Rozenberg, VP Finance of Valens Semiconductor Ltd., filed a Form 4 on November 12, 2026, reporting the sale of 625 ordinary shares on November 9, 2026, pursuant to a Rule 10b5-1 trading plan.
Thomas K. Equels, CEO and President of AIM ImmunoTech Inc., filed a Form 4 on November 12, 2026, disclosing an open-market purchase of 39,000 shares of common stock on November 10, 2026.
Seth Lederman, Chief Executive Officer and Director of Tonix Pharmaceuticals Holding Corp., filed a Form 4 on November 12, 2026, reporting the open-market purchase of 5,000 shares of common stock on November 11, 2026.
Todd M. Hornbeck, President and CEO of Hornbeck Offshore Services, Inc., filed a Form 4 on November 11, 2026, disclosing two open-market purchases of Hornbeck Offshore Services common stock totaling 280,865.849 shares made on November 10 and November 11, 2026.
Trustmark Corporation, the Jackson, Mississippi-based parent of Trustmark Bank, filed an 8-K on November 12, 2026, disclosing the execution of a merger agreement under which Trustmark will merge with and into Hancock Whitney Corporation, with Hancock Whitney continuing as the surviving corporation.
Director Jorey Chernett filed a Form 4 with the SEC on November 12, 2026, disclosing a purchase of call options in Starling Oncology, Inc. (NASDAQ:STLN) on November 11, 2026, and separately noting a calculated short-swing profit the reporting person intends to disgorge to the …
Mark J. Scheiwer, Executive Vice President, CFO and CAO of Scotts Miracle-Gro Co, filed a Form 4 on November 12, 2026, reporting a transaction in common shares dated October 30, 2026.
Exagen Inc. director Jorey Chernett filed a Form 4 on November 12, 2026, disclosing the purchase of 71,315 shares of common stock on November 11, 2026, and noting an intent to disgorge a calculated short-swing profit to the issuer.
Director David C. Evans of Scotts Miracle-Gro Co filed a Form 4 on November 12, 2026, disclosing a sale of common shares on November 9, 2026.
Trustmark Corporation filed a current report on November 12, 2026, disclosing the execution of an Agreement and Plan of Merger with Hancock Whitney Corporation under which Trustmark will merge into Hancock Whitney, with Hancock Whitney continuing as the surviving corporation.